Abstract:Polymeric drugs are a class of drug in which the polymer itself acts as the active ingredient of the drug. Here, we constructed a biodegradable covalent organic porous polymer (COP), denoted as Fc-Ma, composed of clinical drug molecules, i.e., ferrocene (Fc) and D-mannitol (Ma) and pH-responsive acetal bonds. The coexistence of Fc and Ma brought special properties to Fc-Ma, which can be used directly as a polymeric drug integrating the performance of both components. Thus, this special COP features enzyme activity, which can catalyze the conversion of cellular H2O2 to (OH)-O-center dot through a Fenton-like reaction. As an artificial enzyme, Fc-Ma may overcome many of the limitations of natural enzymes with more pronounced catalytic activity in weakly acidic environments. Therefore, it enables the sufficient generation of reactive oxygen species (ROS) in tumors and effectively kills tumor cells. Meanwhile, the intrinsic open porous skeleton coupled with the large specific surface areas (393 m(2) g(-1)) makes Fc-Ma an ideal carrier for other drugs. For example, it presents a doxorubicin hydrochloride (DOX) drug loading capacity of 64.4 +/- 0.27%, compared with individual drugs; the acetal linkage endowed Fc-Ma with passive targeting, resulting in highly controlled drug delivery with selective and sustained release in acidic media, almost twice as much as that under neutral conditions. Hence, the tumor microenvironment can not only stimulate the generation of multiple ROS but also induce the passive targeted release of DOX, thereby ensuring the accumulation of drugs in the cancer sites, preventing the nonspecific distribution of drugs in the whole body and protecting renal tissues against DOX-induced nephrotoxicity. In summary, Fc-Ma-DOX exhibits significant synergistic actions of enzymatic therapy and chemotherapy, thus significantly improving the overall therapeutic effect.

Phenylboronic Acid-Functionalized Copolypeptides: Facile Synthesis and Responsive Dual Anticancer Drug Release

Dual-vectors of Anti-Cancer Drugs and Genes Based on Ph-Sensitive Micelles Self-Assembled from Hybrid Polypeptide Copolymers

Supramolecular polymeric prodrug micelles for efficient anticancer drug delivery

Linear-like polypeptide-based micelle with pH-sensitive detachable PEG to deliver dimeric camptothecin for cancer therapy

Multi-Stimuli-Responsive Nanoparticles Formed of POSS-PEG for the Delivery of Boronic Acid-Containing Therapeutics.

Construction of hyperbranched polysiloxane-based multifunctional fluorescent prodrug for preferential cellular uptake and dual-responsive drug release

Multicomponent Polymeric Nanoparticles Enhancing Intracellular Drug Release in Cancer Cells

Enzymatic drug release cascade from polymeric prodrug nanoassemblies enables targeted chemotherapy

Biodegradable Porous Polymeric Drug with pH-Stimuli-Responsive Delivery Capacity for Combined Cancer Therapy

Ph and Hydrogen Peroxide Dual Responsive Supramolecular Prodrug System for Controlled Release of Bioactive Molecules

Phenylboronic Acid-Functionalized Chitosan for Enabling Transmucosal Delivery for Cancer Therapy

Poly(l-Ornithine)-Based Polymeric Micelles as pH-Responsive Macromolecular Anticancer Agents

Synthesis of Amino‐cosubstituted Polyorganophosphazenes and Fabrication of Their Nanoparticles for Anticancer Drug Delivery

Dual-acidity-labile polysaccharide-di-drugs conjugate for targeted cancer chemotherapy

Construction of Amphiphilic Copolymer Nanoparticles Based on Hyperbranched Poly (Amine-Ester) and 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine As Drug Carriers for Cancer Therapy.

Bioinspired Phospholipid Polymer Prodrug As A Ph-Responsive Drug Delivery System for Cancer Therapy

Drug -driven self-assembly of pH-sensitive nano-vesicles with high loading capacity and anti-tumor efficacy?

Targeted Delivery and Release of Doxorubicin Using A Ph-Responsive and Self-Assembling Copolymer

pH-sensitive polycarbonate micelles for enhanced intracellular release of anticancer drugs: a strategy to circumvent multidrug resistance

Synergistic Therapy of a Naturally Inspired Glycopolymer‐Based Biomimetic Nanomedicine Harnessing Tumor Genomic Instability

Dual stimuli-responsive dendronized prodrug derived from poly(oligo-(ethylene glycol) methacrylate)-based copolymers for enhanced anti-cancer therapeutic effect